The Association of Dysglycaemia and Cardiovascular Disease in Patients with Metabolic Syndrome

By Gong W   Yang Z   Ye W   Du Y   Lu B   Wang M   Li Q   Zhang W   Pan Y   Feng X   Zhou W   Zhang Y   Wen J   Yang Z   Yang Y   Zhu X   Hu R  

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1486-1492

Field House Publishing

Access to resources Recommend Favorite

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5267-5280

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic syndrome: a brain disease

By Gupta Siddharth   Dherange Parinita   De Meester Fabien   Wilczynska Agnieszka   Alam Shaan E.   Pella Daniel   Wilson Douglas W.  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 9, 2012-09 ,pp. : 1171-1183

NRC Research Press

Access to resources Recommend Favorite

Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

By Janero David R   Lindsley Loren   Vemuri Venkata Kiran   Makriyannis Alexandros  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 10, 2011-10 ,pp. : 995-1025

Informa Healthcare

Access to resources Recommend Favorite

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment

By Garruti Gabriella   Depalo Raffaella   Vita Maria Grazia   Lorusso Filomenamila   Giampetruzzi Federica   Damato Aurelia Bellomo   Giorgino Francesco  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 552-563

Reproductive Healthcare Ltd

Access to resources Recommend Favorite